⌘K
Loading ticker…
Collegium Pharmaceutical, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-25, Collegium Pharmaceutical, Inc. Common Stock (COLL) has a 3-month relative strength percentile of 53 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 48 (Neutral). Sector: Healthcare. Average daily range 3.8%, relative volume 0.57×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
53 is not yet a leadership-grade RS read, Market Stance is 48
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
COLL is held by 7 ETFs as of Mar 2026. Top owner: IJR at 0.07% weight, $63M notional. Top 3 carry $119M.
Top 7 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.07% | $63M |
| VTIVanguard Total Stock Market ETF | 0.00% | $31M |
| IWMiShares Russell 2000 ETF | 0.04% | $25M |
| VXFVanguard Extended Market ETF | 0.01% | $12M |
| IWOiShares Russell 2000 Growth ETF | 0.07% | $8M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.78% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COLL Jan avg: 9.85% median: 9.60% win: 75% σ: 9.16% n: 4 2022-04-12 → 2026-05-29 | COLL Feb avg: -3.24% median: -7.39% win: 25% σ: 9.92% n: 4 2022-04-12 → 2026-05-29 | COLL Mar avg: -5.43% median: -3.41% win: 50% σ: 12.12% n: 4 2022-04-12 → 2026-05-29 | COLL Apr avg: -6.72% median: -4.87% win: 20% σ: 7.61% n: 5 2022-04-12 → 2026-05-29 | COLL May avg: -2.16% median: -2.98% win: 20% σ: 6.72% n: 5 2022-04-12 → 2026-05-29 | COLL Jun avg: 2.36% median: -0.58% win: 50% σ: 7.65% n: 4 2022-04-12 → 2026-05-29 (current) | COLL Jul avg: 5.92% median: 3.45% win: 75% σ: 9.93% n: 4 2022-04-12 → 2026-05-29 | COLL Aug avg: 8.71% median: 2.58% win: 75% σ: 14.22% n: 4 2022-04-12 → 2026-05-29 | COLL Sep avg: -5.70% median: -6.72% win: 25% σ: 4.70% n: 4 2022-04-12 → 2026-05-29 | COLL Oct avg: 0.15% median: 0.12% win: 50% σ: 9.91% n: 4 2022-04-12 → 2026-05-29 | COLL Nov avg: 14.67% median: 19.85% win: 75% σ: 17.59% n: 4 2022-04-12 → 2026-05-29 | COLL Dec avg: 4.82% median: 2.63% win: 50% σ: 11.33% n: 4 2022-04-12 → 2026-05-29 |